4-3493384-GCCTGGC-GCCTGGCCCTGGC
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM4
The NM_173660.5(DOK7):c.1403_1408dupGCCCTG(p.Gly468_Pro469dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000546 in 1,594,256 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.00030 ( 0 hom., cov: 35)
Exomes 𝑓: 0.00057 ( 0 hom. )
Consequence
DOK7
NM_173660.5 disruptive_inframe_insertion
NM_173660.5 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.660
Genes affected
DOK7 (HGNC:26594): (docking protein 7) The protein encoded by this gene is essential for neuromuscular synaptogenesis. The protein functions in aneural activation of muscle-specific receptor kinase, which is required for postsynaptic differentiation, and in the subsequent clustering of the acetylcholine receptor in myotubes. This protein can also induce autophosphorylation of muscle-specific receptor kinase. Mutations in this gene are a cause of familial limb-girdle myasthenia autosomal recessive, which is also known as congenital myasthenic syndrome type 1B. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_173660.5.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DOK7 | ENST00000340083.6 | c.1403_1408dupGCCCTG | p.Gly468_Pro469dup | disruptive_inframe_insertion | 7/7 | 1 | NM_173660.5 | ENSP00000344432.5 | ||
DOK7 | ENST00000643608.1 | c.971_976dupGCCCTG | p.Gly324_Pro325dup | disruptive_inframe_insertion | 5/8 | ENSP00000495701.1 | ||||
DOK7 | ENST00000515886.5 | c.473_478dupGCCCTG | p.Gly158_Pro159dup | disruptive_inframe_insertion | 4/4 | 2 | ENSP00000492194.1 | |||
DOK7 | ENST00000507039.5 | c.*624_*629dupGCCCTG | 3_prime_UTR_variant | 7/7 | 2 | ENSP00000423614.1 |
Frequencies
GnomAD3 genomes AF: 0.000296 AC: 45AN: 152240Hom.: 0 Cov.: 35
GnomAD3 genomes
AF:
AC:
45
AN:
152240
Hom.:
Cov.:
35
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000295 AC: 59AN: 200306Hom.: 0 AF XY: 0.000307 AC XY: 34AN XY: 110612
GnomAD3 exomes
AF:
AC:
59
AN:
200306
Hom.:
AF XY:
AC XY:
34
AN XY:
110612
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000573 AC: 826AN: 1442016Hom.: 0 Cov.: 89 AF XY: 0.000555 AC XY: 397AN XY: 715754
GnomAD4 exome
AF:
AC:
826
AN:
1442016
Hom.:
Cov.:
89
AF XY:
AC XY:
397
AN XY:
715754
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000296 AC: 45AN: 152240Hom.: 0 Cov.: 35 AF XY: 0.000134 AC XY: 10AN XY: 74380
GnomAD4 genome
AF:
AC:
45
AN:
152240
Hom.:
Cov.:
35
AF XY:
AC XY:
10
AN XY:
74380
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 28, 2023 | In-frame duplication of 2 amino acids in a non-repeat region; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Nov 01, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jul 24, 2019 | - - |
Fetal akinesia deformation sequence 1;C1850792:Congenital myasthenic syndrome 10 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2022 | This variant, c.1403_1408dup, results in the insertion of 2 amino acid(s) of the DOK7 protein (p.Gly468_Pro469dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs762148551, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with DOK7-related conditions. ClinVar contains an entry for this variant (Variation ID: 639843). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at